Paige
Company profile
Primary focus
Computational pathology solutions using large-scale image and multimodal foundation models for whole-slide image analysis, biomarker prediction, and diagnostic workflow support.
Why it’s included
The company develops and offers 'FullFocus', an FDA-cleared whole-slide image viewer and digital pathology platform, as well as multiple AI applications for whole-slide tissue image analysis, directly addressing digitized-tissue pathology workflows and regulatory requirements.
Relevant capabilities
- Whole-slide image analysis for cancer detection, grading, and subtyping
- High-throughput biomarker prediction from H&E
- Multimodal data integration and automated clinical report generation
- Platform integration, deployment, and image management
- Foundation model development and licensing
Commercial sectorAI-Powered Diagnostic & Decision Support Algorithms
Technology classesImage management systems for digital pathology, Vision transformer pathology image analysis, Cloud-based pathology image analysis platforms, Pathology image compression and format conversion, CNN-based pathology image analysis algorithms, Stain normalization and color calibration, AI training data curation for pathology, Telepathology and remote consultation systems
Relevant commercial products
- Virchow
- Paige PanCancer Suite
- FullFocus
- Pan-tissue cancer detection application
- Paige OmniScreen
Relevant patents
4 families, 5 publications- Systems and methods for processing electronic images for computational detection methods US-11995903-B2
- Systems and methods for processing electronic images US-11210787-B1
- Systems and methods for processing electronic images to infer biomarkers US-12387330-B2
- Systems and methods of automatically processing electronic images across regions US-11791036-B2